Details for New Drug Application (NDA): 019071
✉ Email this page to a colleague
The generic ingredient in UROCIT-K is potassium citrate. There are two hundred and forty drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.
Summary for 019071
Tradename: | UROCIT-K |
Applicant: | Mission Pharma |
Ingredient: | potassium citrate |
Patents: | 0 |
Pharmacology for NDA: 019071
Mechanism of Action | Acidifying Activity Calcium Chelating Activity |
Physiological Effect | Decreased Coagulation Factor Activity |
Medical Subject Heading (MeSH) Categories for 019071
Suppliers and Packaging for NDA: 019071
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
UROCIT-K | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 019071 | NDA | Mission Pharmacal Company | 0178-0600 | 0178-0600-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0178-0600-01) |
UROCIT-K | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 019071 | NDA | Mission Pharmacal Company | 0178-0610 | 0178-0610-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0178-0610-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 5MEQ | ||||
Approval Date: | Aug 30, 1985 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MEQ | ||||
Approval Date: | Aug 31, 1992 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 15MEQ | ||||
Approval Date: | Dec 30, 2009 | TE: | AB | RLD: | Yes |
Complete Access Available with Subscription